AV

Aman Vallabhabhai Ardeshna

Active Director Designated Partner DIN 11915962
DIN 11915962 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Aman Vallabhabhai Ardeshna

Aman Vallabhabhai Ardeshna is a Designated Partner at Nova Veterinary Llp (since 2026).

DIN 11915962
Primary Designation Designated Partner
First Appointment 28 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Aug 20262026Active

Board colleagues of Aman Vallabhabhai Ardeshna

NameDINCompanyDesignation
Ashok Ramanbhai Patel11915964Nova Veterinary LlpDesignated Partner
Nishant Shukla11915963Nova Veterinary LlpDesignated Partner
Tanya Nirav Adalja09474546Nova Veterinary LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Nova Veterinary Llp
Premium access

Shareholding and investment profile for Aman Vallabhabhai Ardeshna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aman Vallabhabhai Ardeshna

Aman Vallabhabhai Ardeshna currently holds 1 directorship: Nova Veterinary Llp (Designated Partner, since 28 Aug 2026).

Aman Vallabhabhai Ardeshna was first appointed on 28 Aug 2026 as Designated Partner at Nova Veterinary Llp.

The current boards of Aman Vallabhabhai Ardeshna's companies include Ashok Ramanbhai Patel (Nova Veterinary Llp), Nishant Shukla (Nova Veterinary Llp), Tanya Nirav Adalja (Nova Veterinary Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available